Severe OSA May Be Associated With Endothelial Dysfunction in Patients With Nocturnal Hypertension
Krish Dodani1, Clémentine Puech2, Lucía Pinilla3
1Department of Nursing and Physiotherapy, Universitat de Lleida, Lleida, Spain; Institut de Recerca Biomèdica de Lleida - Fundació Dr. Pifarré, IRBLleida, Group of Translational Research in Respiratory Medicine, Av. Alcalde Rovira Roure 80, 25198 Lleida, Spain.
Nocturnal hypertension (NH) is linked to severe obstructive sleep apnea (OSA), with molecular changes suggesting endothelial dysfunction. This research provides insight into cardiovascular risk in NH patients with OSA.
Area of Science:
- Cardiovascular Science
- Sleep Medicine
- Proteomics
Background:
- Nocturnal hypertension (NH) is a high-risk cardiovascular condition.
- Obstructive sleep apnea (OSA) is common in NH patients and linked to vascular injury.
- Molecular mechanisms connecting NH and OSA-induced vascular damage are poorly understood.
Purpose of the Study:
- To explore molecular mechanisms linking NH and severe OSA.
- To investigate protein alterations and endothelial dysfunction in NH patients with OSA.
- To utilize targeted proteomics and endothelial cell models.
Main Methods:
- Included adults with NH undergoing polysomnography (PSG).
- Classified participants into control (AHI <15) and severe OSA (AHI ≥30) groups, matched for key demographics and BP.
- Quantified proteins using Olink® platform and assessed endothelial integrity in cell models exposed to extracellular vesicles.
Main Results:
- 21 differentially abundant proteins were identified, enriched in cell adhesion and extracellular vesicle pathways.
- A 13-protein signature associated with OSA was linked to endothelial regulatory pathways.
- Extracellular vesicles from severe OSA patients showed a trend towards increased endothelial barrier disruption.
Conclusions:
- Severe OSA is associated with molecular alterations indicating endothelial dysfunction in NH patients.
- These findings offer preliminary mechanistic insights into the elevated cardiovascular risk.
- This may aid in refining risk stratification for NH patients with OSA.
Related Concept Videos
Sleep Apnea
The condition is more prevalent among...
Heart Failure VI: Adjunct Therapies
Hypertension II: Pathophysiology
Hypertension III: Clinical Manifestations and Diagnostic Studies
Measurement of Blood Pressure
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...

